ProfileGDS4718 / 229173_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 80% 83% 76% 79% 82% 79% 75% 82% 79% 81% 80% 75% 81% 77% 80% 86% 84% 80% 72% 51% 81% 83% 85% 80% 85% 75% 82% 74% 83% 82% 79% 79% 84% 82% 60% 73% 82% 79% 86% 77% 85% 78% 71% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.8735180
GSM549102patient 115, normal, homogenized [OPG study]8.1565583
GSM549104patient 119, normal, homogenized [OPG study]7.5307776
GSM549108patient 138, normal, homogenized [OPG study]7.6873779
GSM549119patient 077, normal, homogenized [OPG study]8.0064682
GSM549133patient 032, cancer, homogenized [OPG study]7.8304979
GSM549139patient 042, cancer, homogenized [OPG study]7.3579775
GSM549099patient 107, normal, homogenized [OPG study]8.0542782
GSM549109patient 139, normal, homogenized [OPG study]7.6863979
GSM549110patient 046, normal, homogenized [OPG study]7.9605681
GSM549114patient 063, normal, homogenized [OPG study]7.9652280
GSM549122patient 082, normal, homogenized [OPG study]7.353375
GSM549134patient 033, cancer, homogenized [OPG study]7.996481
GSM549136patient 036, cancer, homogenized [OPG study]7.6048177
GSM549140patient 044, cancer, homogenized [OPG study]7.9746680
GSM549111patient 047, normal, homogenized [OPG study]8.7310286
GSM549113patient 057, normal, homogenized [OPG study]8.4546684
GSM549132patient 031, cancer, homogenized [OPG study]7.8607880
GSM549137patient 038, cancer, homogenized [OPG study]7.0940272
GSM549142patient 047, cancer, homogenized [OPG study]5.7134151
GSM549100patient 110, normal, homogenized [OPG study]7.9046381
GSM549107patient 135, normal, homogenized [OPG study]8.215483
GSM549115patient 068, normal, homogenized [OPG study]8.5792385
GSM549116patient 072, normal, homogenized [OPG study]7.9086180
GSM549120patient 078, normal, homogenized [OPG study]8.5248485
GSM549131patient 030, cancer, homogenized [OPG study]7.4919875
GSM549118patient 074, normal, homogenized [OPG study]8.156482
GSM549129patient 027, cancer, homogenized [OPG study]7.3098474
GSM549123patient 088, normal, homogenized [OPG study]8.2350283
GSM549124patient 006, cancer, homogenized [OPG study]8.022482
GSM549126patient 015, cancer, homogenized [OPG study]7.7437379
GSM549128patient 025, cancer, homogenized [OPG study]7.818379
GSM549103patient 117, normal, homogenized [OPG study]8.1686684
GSM549117patient 073, normal, homogenized [OPG study]8.1279182
GSM549138patient 041, cancer, homogenized [OPG study]6.1424260
GSM549141patient 045, cancer, homogenized [OPG study]7.3001473
GSM549130patient 028, cancer, homogenized [OPG study]8.0290282
GSM549101patient 111, normal, homogenized [OPG study]7.6952479
GSM549105patient 128, normal, homogenized [OPG study]8.5096186
GSM549106patient 134, normal, homogenized [OPG study]7.6555777
GSM549112patient 048, normal, homogenized [OPG study]8.4957285
GSM549125patient 011, cancer, homogenized [OPG study]7.5628378
GSM549127patient 024, cancer, homogenized [OPG study]7.0388671
GSM549135patient 035, cancer, homogenized [OPG study]7.1856673